Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis

Date

2014

Author

Kalincik, T.
Horakova, D.
Spelman, T.
Jokubaitis, V.
Trojano, M.
Lugaresi, A.
Bergamaschi, R.

Metadata

Show full item record

Abstract

…

Source

Multiple Sclerosis Journal

Volume

20

URI

https://hdl.handle.net/20.500.12712/15031

Collections